These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33408786)

  • 1. Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (
    Varasteh Z; De Rose F; Mohanta S; Li Y; Zhang X; Miritsch B; Scafetta G; Yin C; Sager HB; Glasl S; Gorpas D; Habenicht AJR; Ntziachristos V; Weber WA; Bartolazzi A; Schwaiger M; D'Alessandria C
    Theranostics; 2021; 11(4):1864-1876. PubMed ID: 33408786
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
    Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
    Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer.
    Parent EE; Gleba JJ; Knight JA; Kenderian SJ; Copland JA; Cai H
    Mol Imaging Biol; 2024 Oct; 26(5):847-857. PubMed ID: 39174789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
    Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
    J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.
    De Rose F; Braeuer M; Braesch-Andersen S; Otto AM; Steiger K; Reder S; Mall S; Nekolla S; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C
    J Nucl Med; 2019 Jun; 60(6):770-776. PubMed ID: 30361380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.
    Sham JG; Kievit FM; Grierson JR; Chiarelli PA; Miyaoka RS; Zhang M; Yeung RS; Minoshima S; Park JO
    J Nucl Med; 2014 Dec; 55(12):2032-7. PubMed ID: 25359880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive
    Peplau E; De Rose F; Reder S; Mittelhäuser M; Scafetta G; Schwaiger M; Weber WA; Bartolazzi A; Skerra A; D'Alessandria C
    Thyroid; 2020 Sep; 30(9):1314-1326. PubMed ID: 32200708
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using
    Varasteh Z; Hyafil F; Anizan N; Diallo D; Aid-Launais R; Mohanta S; Li Y; Braeuer M; Steiger K; Vigne J; Qin Z; Nekolla SG; Fabre JE; Döring Y; Le Guludec D; Habenicht A; Vera DR; Schwaiger M
    EJNMMI Res; 2017 Dec; 7(1):40. PubMed ID: 28470406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-PET Imaging of Atherosclerotic Plaques with [
    Poels K; Schreurs M; Jansen M; Vugts DJ; Seijkens TTP; van Dongen GAMS; Lutgens E; Beaino W
    Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage.
    Suzuki M; Katayama T; Suzuki C; Nakajima K; Magata Y; Ogawa M
    Nucl Med Biol; 2021; 102-103():45-55. PubMed ID: 34619460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals.
    Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW
    Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.
    Jagoda EM; Vasalatiy O; Basuli F; Opina ACL; Williams MR; Wong K; Lane KC; Adler S; Ton AT; Szajek LP; Xu B; Butcher D; Edmondson EF; Swenson RE; Greiner J; Gulley J; Eary J; Choyke PL
    Mol Imaging; 2019; 18():1536012119829986. PubMed ID: 31044647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [
    Meletta R; Slavik R; Mu L; Rancic Z; Borel N; Schibli R; Ametamey SM; Krämer SD; Müller Herde A
    Nucl Med Biol; 2017 Apr; 47():31-43. PubMed ID: 28104528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.
    Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y
    Biochem Biophys Res Commun; 2013 Mar; 433(1):47-51. PubMed ID: 23485468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing
    Wuensche TE; Stergiou N; Mes I; Verlaan M; Schreurs M; Kooijman EJM; Janssen B; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; Beaino W; Dongen GAMS; Vugts DJ
    Theranostics; 2022; 12(16):7067-7079. PubMed ID: 36276653
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Price EW; Carnazza KE; Carlin SD; Cho A; Edwards KJ; Sevak KK; Glaser JM; de Stanchina E; Janjigian YY; Lewis JS
    J Nucl Med; 2017 Sep; 58(9):1386-1394. PubMed ID: 28280216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using
    Varasteh Z; Mohanta S; Li Y; López Armbruster N; Braeuer M; Nekolla SG; Habenicht A; Sager HB; Raes G; Weber W; Hernot S; Schwaiger M
    EJNMMI Res; 2019 Jan; 9(1):5. PubMed ID: 30666513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.